
BIOVERSE Asia 2026
Descrição
"Transforming drug discovery from early research to clinical application"
Destaques
Integration of AI and advanced technologies across drug discovery and development. Exploration of multi-omic insights driving digital discovery. Sessions on bio-discovery through AI. Discussion on next-generation R&D technologies. Focus on digital health and the future of AI in biological research. Designed for scientific and technology leaders advancing drug discovery. Opportunities for networking with over 20 speakers and 7+ hours of networking. Poster presentations and exhibitions of products & technology. Confirmed speakers include Rafik Fellague-Chebra from Novartis and Michael Winther from Engine Biosciences. Venue details to be announced; event to be held in Singapore.
Localização do evento
Diga à sua rede que vai participar
Partilhe este evento para iniciar conversas, convidar colegas e conectar-se antes que comece.
